Home › NDC Lookup › RxCUI directory › RxCUI 866912

Colesevelam hydrochloride 625 MG Oral Tablet [Welchol] — RxCUI 866912

RxNorm drug concept · Semantic branded drug
RxCUI 866912 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI866912
Official nameColesevelam hydrochloride 625 MG Oral Tablet [Welchol]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asWelchol 625 MG Oral Tablet
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)608 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Colesevelam: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It lowers LDL cholesterol in adults with high cholesterol and in teens ages 10 to 17 with an inherited form called HeFH. Some products, including Welchol, are also used to improve...
  • Take it with a meal. Tablets go down with a liquid, and the powder is stirred into water, juice, or diet soda. Follow your prescriber’s directions and your label for how much.
  • Constipation, indigestion, and nausea are the most common. Call your doctor or get help for severe belly pain, severe constipation, or trouble swallowing.
  • Some medicines need spacing. Take things like thyroid medicine, phenytoin, birth control pills, olmesartan, sulfonylureas, cyclosporine, and vitamins at least 4 hours before colese...
📖 Read our full Colesevelam guide →

🕸️ Concept Web — How Colesevelam hydrochloride 625 MG Oral Tablet [We... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Colesevelam hydrochloride 625 MG Oral Tablet [Welchol] RxCUI 866912

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Colesevelam 141626
    • Colesevelam hydrochloride 141625
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Welchol 284918
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Colesevelam Oral Tablet 374632
    • Colesevelam hydrochloride Oral Tablet 2649493
    • Colesevelam Oral Product 1164984
    • Colesevelam Pill 1164985
    • Colesevelam hydrochloride Oral Product 2661751
    • Colesevelam hydrochloride Pill 2659909
    • Colesevelam Oral Tablet [Welchol] 368175
    • Colesevelam hydrochloride Oral Tablet [Welchol] 2654403
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Colesevelam hydrochloride 625 MG Oral Tablet SCD · 866910
  • Colesevelam hydrochloride 625 MG SCDC · 866909
  • Colesevelam Oral Tablet SCDF · 374632
  • Colesevelam hydrochloride Oral Tablet SCDFP · 2649493
  • Colesevelam Oral Product SCDG · 1164984
  • Colesevelam Pill SCDG · 1164985
  • Colesevelam hydrochloride Oral Product SCDGP · 2661751
  • Colesevelam hydrochloride Pill SCDGP · 2659909

Brand-Name Concepts

  • Colesevelam hydrochloride 625 MG [Welchol] SBDC · 866911
  • Colesevelam Oral Tablet [Welchol] SBDF · 368175
  • Colesevelam hydrochloride Oral Tablet [Welchol] SBDFP · 2654403
  • Welchol Oral Product SBDG · 1187941
  • Welchol Pill SBDG · 1187942
  • Welchol BN · 284918

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 866912 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00713-0879-81 180 TABLET, FILM COATED in 1 BOTTLE (0713-0879-81) Welchol Cosette Pharmaceuticals, Inc. 2022-09-01
00713-0880-30 30 PACKET in 1 CARTON (0713-0880-30) / 1 FOR SUSPENSION in... Welchol Cosette Pharmaceuticals, Inc. 2022-09-01
Observed labelers: Cosette Pharmaceuticals, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.